Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Laura Bartels-Peculis, Ajay Sharma, Alison M Edwards, Anirudh Sanyal, Erin Connolly-Strong & Winnie W Nelson. (2020) Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population. Open Access Rheumatology: Research and Reviews 12, pages 117-124.
Read now
Read now
Articles from other publishers (20)
Rodolfo Nicolas Alvarado, Gelsomina Alle, Mayra Alejandra Tobar–Jaramillo, Luis Carlos Palomino, Agustín Gabriel Cáceres, Javier Eduardo Rosa, Gerardo Machnicki, Federico Zazzetti, Enrique Soriano & Marina Scolnik. (2023) Burden of lupus activity on health care resources utilization in Buenos Aires, Argentina. Lupus 32:14, pages 1656-1665.
Crossref
Crossref
Elena Garal-Pantaler, Michael Schultze, Mary Elizabeth Georgiou, Marc Pignot, Kerry Gairy & Jacob N. Hunnicutt. (2023) Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis. Rheumatology and Therapy.
Crossref
Crossref
Christopher F Bell, Benjamin Wu, Shirley P Huang, Bernard Rubin, Carlyne M Averell, Benjamin Chastek, Erin M Hulbert & Joan Von Feldt. (2023) Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis. Cureus.
Crossref
Crossref
Ann E. Clarke, John G. Hanly, Murray B. Urowitz, Yvan St. Pierre, Caroline Gordon, Sang‐Cheol Bae, Juanita Romero‐Diaz, Jorge Sanchez‐Guerrero, Sasha Bernatsky, Daniel J. Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Michelle Petri, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey‐Goldman, Susan Manzi, Andreas Jönsen, Graciela S. Alarcón, Ronald F. Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz‐Irastorza, S. Sam Lim, Murat Inanc, Kenneth C. Kalunian, Soren Jacobsen, Christine A. Peschken, Diane L. Kamen, Anca Askanase & Vernon Farewell. (2023) Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling. Arthritis Care & Research.
Crossref
Crossref
Maria Dall’EraKenneth KalunianMichael EaddyAugustina OgbonnayaEileen FarrellyEric TurowskiVanessa BirardiNeil SolomonsSimrat RandhawaPaola Mina-Osorio. (2023) Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United States. Journal of Managed Care & Specialty Pharmacy 29:1, pages 36-45.
Crossref
Crossref
Dora H Lin, Irene B Murimi-Worstell, Hong Kan, Jonothan C Tierce, Xia Wang, Henk Nab, Barnabas Desta, Edward R Hammond & G Caleb Alexander. (2022) Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. Lupus 31:7, pages 773-807.
Crossref
Crossref
Sergio I Prada, Ana M Pérez, Ivana Nieto-Aristizábal & Gabriel J Tobón. (2022) Increase in direct costs for health systems due to lupus nephritis: the case of Colombia. Einstein (São Paulo) 20.
Crossref
Crossref
Juliette C. Thompson, Anadi Mahajan, David A. Scott & Kerry Gairy. (2021) The Economic Burden of Lupus Nephritis: A Systematic Literature Review. Rheumatology and Therapy 9:1, pages 25-47.
Crossref
Crossref
Katarzyna Pawlak-Buś, Wiktor Schmidt & Piotr Leszczyński. (2021) Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus. Journal of Clinical Medicine 10:20, pages 4788.
Crossref
Crossref
Irina A. Pashnina, Irina M. Krivolapova, Tamara V. Fedotkina, Varvara A. Ryabkova, Margarita V. Chereshneva, Leonid P. Churilov & Valeriy A. Chereshnev. (2021) Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease. Antibodies 10:1, pages 9.
Crossref
Crossref
Rezzan Eren Sadioglu, Sahin Eyupoglu, Siyar Erdogmus, Gizem Kumru Sahin, Fugen Yoruk, Sim Kutlay, Kenan Keven, Sehsuvar Erturk & Sule Sengul. (2021) Infectious Complications in Patients with Primary Glomerulonephritis over 10 Years: A Single-Center Experience in Turkey. Kidney Diseases 7:1, pages 57-66.
Crossref
Crossref
Megan R. W. Barber, John G. Hanly, Li Su, Murray B. Urowitz, Yvan St. Pierre, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Sasha Bernatsky, Daniel J. Wallace, David A. Isenberg, Anisur Rahman, Ellen M. Ginzler, Michelle Petri, Ian N. Bruce, Paul R. Fortin, Dafna D. Gladman, Jorge Sanchez-Guerrero, Rosalind Ramsey-Goldman, Munther A. Khamashta, Cynthia Aranow, Meggan Mackay, Graciela S. Alarcón, Susan Manzi, Ola Nived, Andreas Jönsen, Asad A. Zoma, Ronald F. van Vollenhoven, Manuel Ramos-Casals, Guillermo Ruiz-Irastorza, S. Sam Lim, Kenneth C. Kalunian, Murat Inanc, Diane L. Kamen, Christine A. Peschken, Soren Jacobsen, Anca Askanase, Chris Theriault, Vernon Farewell & Ann E. Clarke. (2018) Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach. Arthritis Care & Research 70:9, pages 1294-1302.
Crossref
Crossref
Sean Barbour, Clifford Lo, Gabriela Espino-Hernandez, Jagbir Gill & Adeera Levin. (2018) The BC Glomerulonephritis Network: Improving Access and Reducing the Cost of Immunosuppressive Treatments for Glomerular Diseases. Canadian Journal of Kidney Health and Disease 5, pages 205435811875955.
Crossref
Crossref
Edith M. Williams, Leonard Egede, Trevor Faith & James Oates. (2017) Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring. The American Journal of the Medical Sciences 353:6, pages 580-592.
Crossref
Crossref
Y. M. Chiu, M. T. Chuang & H. C. Lang. (2016) Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study. Rheumatology International 36:11, pages 1507-1514.
Crossref
Crossref
G Bertsias, E Karampli, P Sidiropoulos, I Gergianaki, A Drosos, L Sakkas, A Garyfallos, A Tzioufas, D Vassilopoulos, C Tsalapaki, P Sfikakis, S Panopoulos, K Athanasakis, A Perna, D Psomali, J Kyriopoulos & D Boumpas. (2016) Clinical and financial burden of active lupus in Greece: a nationwide study. Lupus 25:12, pages 1385-1394.
Crossref
Crossref
Erin E. Carter, Susan G. Barr & Ann E. Clarke. (2016) The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nature Reviews Rheumatology 12:10, pages 605-620.
Crossref
Crossref
M Y Choi, M R W Barber, C E H Barber, A E Clarke & M J Fritzler. (2016) Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care. Lupus 25:8, pages 838-849.
Crossref
Crossref
Andreas Jönsen, Frida Hjalte, Minna Willim, Katarina Steen Carlsson, Christopher Sjöwall, Elisabet Svenungsson, Dag Leonard, Christine Bengtsson, Solbritt Rantapää- Dahlqvist, Susanne Pettersson, Iva Gunnarsson, Agneta Zickert, Johanna T. Gustafsson, Lars Rönnblom, Ingemar F. Petersson, Anders A. Bengtsson & Ola Nived. (2016) Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts. Seminars in Arthritis and Rheumatism 45:6, pages 684-690.
Crossref
Crossref
Marvin J. Fritzler. (2016) Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing. Autoimmunity Reviews 15:3, pages 272-280.
Crossref
Crossref